NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,280,000 | -35.8% | 116,224 | -30.3% | 1.44% | -54.5% |
| Q1 2018 | $14,452,000 | +34.3% | 166,744 | +7.0% | 3.17% | +7.5% |
| Q4 2017 | $10,764,000 | +97.7% | 155,904 | +160.3% | 2.95% | +71.2% |
| Q3 2017 | $5,444,000 | +23.2% | 59,905 | +0.9% | 1.72% | +16.3% |
| Q2 2017 | $4,418,000 | – | 59,358 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |